M. Amrani
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- Cancer-related molecular mechanisms research
Papers in
- Co-authors
- Mohammed El Mzibri (11 shared papers)Saïd Afqir (7 shared papers)Khalid El Bairi (7 shared papers)Rachid Razıne (4 shared papers)Mohammed Attaleb (5 shared papers)Mounia Oudghiri (3 shared papers)Atanas G. Atanasov (1 shared paper)Hassan Errihani (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (2 papers)Archives of Gynecology and Obstetrics (1 paper)Pathogens (1 paper)PLoS ONE (1 paper)Expert Review of Clinical Pharmacology (1 paper)
- Partner nations
- MoroccoFranceUnited States
In The Last Decade
M. Amrani
41 papers receiving 464 citations
Peers
Comparison fields: 5 of 78
- Reproductive Medicine 50
- Cancer Research 66
- Oncology 111
- Pharmacology 23
- Epidemiology 76
Countries citing papers authored by M. Amrani
This map shows the geographic impact of M. Amrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Amrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Amrani more than expected).
Fields of papers citing papers by M. Amrani
This network shows the impact of papers produced by M. Amrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Amrani. The network helps show where M. Amrani may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Amrani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 39 | |
| 2 | 2014 | 28 | |
| 3 | 2016 | 26 | |
| 4 | 2014 | 25 | |
| 5 | 2002 | 25 | |
| 6 | 2014 | 24 | |
| 7 | 2017 | 24 | |
| 8 | 2018 | 22 | |
| 9 | 2003 | 19 | |
| 10 | 2011 | 18 | |
| 11 | 2009 | 18 | |
| 12 | 2011 | 16 | |
| 13 | 2016 | 16 | |
| 14 | 2011 | 13 | |
| 15 | 2010 | 13 | |
| 16 | 2005 | 12 | |
| 17 | 2019 | 12 | |
| 18 | EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women. | 2010 | 11 |
| 19 | 2020 | 10 | |
| 20 | 2020 | 10 |
About M. Amrani
M. Amrani is a scholar working on Oncology, Surgery, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 484 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (4 papers), Testicular diseases and treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Urologic and reproductive health conditions (2 papers) and Ear and Head Tumors (2 papers). The work is most often cited by research in Reproductive Medicine (50 citations), Cancer Research (66 citations), Oncology (111 citations), Pharmacology (23 citations) and Epidemiology (76 citations). M. Amrani has collaborated with scholars based in Morocco, France and United States. Frequent co-authors include Mohammed El Mzibri, Saïd Afqir, Khalid El Bairi, Rachid Razıne, Mohammed Attaleb, Mounia Oudghiri, Atanas G. Atanasov, Hassan Errihani, Brahim Saadani and Noureddine Louanjli. Their work appears in journals such as Biomedicine & Pharmacotherapy, Archives of Gynecology and Obstetrics, Pathogens, PLoS ONE and Expert Review of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.